< 1 minute read
Sep. 18, 2021
"compound 15a"
reversible ATX inhibitor w/ alt. binding mode in vivo PD observed on oral dosing from HTS screen and opt. Bioorg. Med. Chem. Lett., Nov. 4, 2020 Novartis, Horsham, UK / Basel, CH
Loading...
reversible ATX inhibitor w/ alt. binding mode in vivo PD observed on oral dosing from HTS screen and opt. Bioorg. Med. Chem. Lett., Nov. 4, 2020 Novartis, Horsham, UK / Basel, CH